Geneos Wealth Management’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Geneos Wealth Management’s Portfolio SBIO Stock Details SBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,000	Closed	-$42K	–	2589
2019 Q4	$42K	Hold	1,000	–	–	﹤0.01%	1346
2019 Q3	$32K	Hold	1,000	–	–	﹤0.01%	1396
2019 Q2	$36K	Hold	1,000	–	–	﹤0.01%	1355
2019 Q1	$36K	Hold	1,000	–	–	﹤0.01%	1308
2018 Q4	$27K	Sell	1,000 -1,150	-53%	-$38.1K	﹤0.01%	1375
2018 Q3	$84K	Buy	2,150 +1,250	+139%	+$47.4K	0.01%	953
2018 Q2	$33K	Hold	900	–	–	﹤0.01%	1242
2018 Q1	$30K	Hold	900	–	–	﹤0.01%	1227
2017 Q4	$29K	Buy	900 +100	+13%	+$3.13K	﹤0.01%	1249
2017 Q3	$24K	Buy	+800	New	+$23.5K	﹤0.01%	1257
2016 Q4	–	Sell	-500	Closed	-$13K	–	2084
2016 Q3	$13K	Hold	500	–	–	﹤0.01%	1284
2016 Q2	$11K	Buy	+500	New	+$11.9K	﹤0.01%	1300

Other funds holding SBIO

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

NAM

NTV Asset Management Charleston, West Virginia $1.02B AUM 31.16% 1-Year Est. Return

CCP

Cardan Capital Partners Denver, Colorado $893M AUM 22.82% 1-Year Est. Return

Geneos Wealth Management's SBIO Position: Q1 2020 in Review

Geneos Wealth Management sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q1 2020, closing a stake of 1,000 shares — an estimated $42K sold.

Geneos Wealth Management first reported a position in SBIO in Q2 2016 and held it in 12 quarters. The position peaked at $84K in Q3 2018. 46 funds tracked by Wall St. Rank hold SBIO as of Q1 2020.

Geneos Wealth Management reported no remaining ALPS Medical Breakthroughs ETF position as of Q1 2020 after selling out during the quarter.
Geneos Wealth Management sold 1,000 ALPS Medical Breakthroughs ETF shares in Q1 2020, an estimated $42K.
Geneos Wealth Management first reported a position in ALPS Medical Breakthroughs ETF in Q2 2016 and held it in 12 quarters.
Geneos Wealth Management's ALPS Medical Breakthroughs ETF position peaked at $84K in Q3 2018.
46 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q1 2020.

Based on Geneos Wealth Management's 13F filing for Q1 2020, filed 7 Sep 2021.